25 XP   0   0   10

Akoya Biosciences Inc
Buy, Hold or Sell?

Let's analyse Akoya Biosciences Inc together

PenkeI guess you are interested in Akoya Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Akoya Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Akoya Biosciences Inc

I send you an email if I find something interesting about Akoya Biosciences Inc.

Quick analysis of Akoya Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Akoya Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
31.3%

What is your share worth?

Current worth
$1.09
Expected worth in 1 year
$1.00
How sure are you?
18.8%

+ What do you gain per year?

Total Gains per Share
$-0.10
Return On Investment
-2.1%

For what price can you sell your share?

Current Price per Share
$4.69
Expected price per share
$4.25 - $6.31
How sure are you?
50%

1. Valuation of Akoya Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$4.69

Intrinsic Value Per Share

$-11.32 - $-13.17

Total Value Per Share

$-10.22 - $-12.07

2. Growth of Akoya Biosciences Inc (5 min.)




Is Akoya Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$53.7m$82.7m-$25.3m-44.1%

How much money is Akoya Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$15.8m-$17.6m$1.8m11.6%
Net Profit Margin-67.1%-94.6%--

How much money comes from the company's main activities?

3. Financial Health of Akoya Biosciences Inc (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#119 / 173

Most Revenue
#111 / 173

Most Profit
#161 / 173

Most Efficient
#146 / 173

What can you expect buying and holding a share of Akoya Biosciences Inc? (5 min.)

Welcome investor! Akoya Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Akoya Biosciences Inc.

What can you expect buying and holding a share of Akoya Biosciences Inc?

First you should know what it really means to hold a share of Akoya Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Akoya Biosciences Inc is $4.69. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Akoya Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Akoya Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.09. Based on the TTM, the Book Value Change Per Share is $-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.32 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Akoya Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.22-4.7%-0.32-6.9%-0.36-7.7%-0.25-5.4%-0.25-5.4%
Usd Book Value Change Per Share-0.17-3.6%-0.02-0.5%-0.32-6.8%0.071.5%0.071.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.1%0.010.1%
Usd Total Gains Per Share-0.17-3.6%-0.02-0.5%-0.32-6.8%0.081.6%0.081.6%
Usd Price Per Share4.88-6.28-11.29-7.43-7.43-
Price to Earnings Ratio-5.55--4.92--7.89--7.22--7.22-
Price-to-Total Gains Ratio-29.23--16.13--35.46--29.96--29.96-
Price to Book Ratio4.46-5.69-6.93-4.26-4.26-
Price-to-Total Gains Ratio-29.23--16.13--35.46--29.96--29.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.69
Number of shares213
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.020.07
Usd Total Gains Per Share-0.020.08
Gains per Quarter (213 shares)-5.1716.06
Gains per Year (213 shares)-20.7064.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-21-3165854
20-42-5212117118
30-63-7318175182
41-83-9424233246
51-104-11530291310
61-125-13636350374
71-146-15742408438
81-167-17848466502
91-188-19954524566
102-209-22060583630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.016.00.00.0%0.016.00.00.0%0.016.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%3.010.03.018.8%3.010.03.018.8%3.010.03.018.8%
Dividend per Share1.00.03.025.0%5.00.07.041.7%5.00.011.031.3%5.00.011.031.3%5.00.011.031.3%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%3.010.03.018.8%3.010.03.018.8%3.010.03.018.8%

Fundamentals of Akoya Biosciences Inc

About Akoya Biosciences Inc

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-20 09:16:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Akoya Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Akoya Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Akoya Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -40.8% means that $-0.41 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Akoya Biosciences Inc:

  • The MRQ is -40.8%. The company is making a huge loss. -2
  • The TTM is -67.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-40.8%TTM-67.1%+26.3%
TTM-67.1%YOY-94.6%+27.6%
TTM-67.1%5Y-69.5%+2.4%
5Y-69.5%10Y-69.5%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.8%6.2%-47.0%
TTM-67.1%7.4%-74.5%
YOY-94.6%8.0%-102.6%
5Y-69.5%7.1%-76.6%
10Y-69.5%7.7%-77.2%
1.1.2. Return on Assets

Shows how efficient Akoya Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Akoya Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • -6.0% Return on Assets means that Akoya Biosciences Inc generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Akoya Biosciences Inc:

  • The MRQ is -6.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.0%TTM-9.1%+3.1%
TTM-9.1%YOY-9.8%+0.7%
TTM-9.1%5Y-7.0%-2.1%
5Y-7.0%10Y-7.0%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.0%1.2%-7.2%
TTM-9.1%1.2%-10.3%
YOY-9.8%1.7%-11.5%
5Y-7.0%1.6%-8.6%
10Y-7.0%1.6%-8.6%
1.1.3. Return on Equity

Shows how efficient Akoya Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Akoya Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • -20.1% Return on Equity means Akoya Biosciences Inc generated $-0.20 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Akoya Biosciences Inc:

  • The MRQ is -20.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -28.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.1%TTM-28.6%+8.5%
TTM-28.6%YOY-22.7%-6.0%
TTM-28.6%5Y-16.4%-12.2%
5Y-16.4%10Y-16.4%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.1%2.3%-22.4%
TTM-28.6%2.6%-31.2%
YOY-22.7%3.1%-25.8%
5Y-16.4%3.2%-19.6%
10Y-16.4%3.0%-19.4%

1.2. Operating Efficiency of Akoya Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Akoya Biosciences Inc is operating .

  • Measures how much profit Akoya Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Akoya Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -33.3% means the company generated $-0.33  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Akoya Biosciences Inc:

  • The MRQ is -33.3%. The company is operating very inefficient. -2
  • The TTM is -62.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-33.3%TTM-62.7%+29.4%
TTM-62.7%YOY-88.9%+26.2%
TTM-62.7%5Y-61.4%-1.2%
5Y-61.4%10Y-61.4%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-33.3%7.9%-41.2%
TTM-62.7%6.4%-69.1%
YOY-88.9%10.7%-99.6%
5Y-61.4%10.0%-71.4%
10Y-61.4%8.4%-69.8%
1.2.2. Operating Ratio

Measures how efficient Akoya Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.33 means that the operating costs are $1.33 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Akoya Biosciences Inc:

  • The MRQ is 1.333. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.571. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.333TTM1.571-0.238
TTM1.571YOY1.889-0.317
TTM1.5715Y1.599-0.027
5Y1.59910Y1.5990.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3331.099+0.234
TTM1.5711.149+0.422
YOY1.8891.109+0.780
5Y1.5991.101+0.498
10Y1.5991.055+0.544

1.3. Liquidity of Akoya Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Akoya Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 3.45 means the company has $3.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Akoya Biosciences Inc:

  • The MRQ is 3.446. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.218. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.446TTM3.218+0.228
TTM3.218YOY3.522-0.304
TTM3.2185Y3.248-0.031
5Y3.24810Y3.2480.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4462.385+1.061
TTM3.2182.589+0.629
YOY3.5222.582+0.940
5Y3.2482.635+0.613
10Y3.2482.614+0.634
1.3.2. Quick Ratio

Measures if Akoya Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Akoya Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 2.83 means the company can pay off $2.83 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Akoya Biosciences Inc:

  • The MRQ is 2.833. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.635. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.833TTM2.635+0.197
TTM2.635YOY3.466-0.831
TTM2.6355Y2.906-0.271
5Y2.90610Y2.9060.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8331.165+1.668
TTM2.6351.172+1.463
YOY3.4661.283+2.183
5Y2.9061.392+1.514
10Y2.9061.477+1.429

1.4. Solvency of Akoya Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Akoya Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Akoya Biosciences Inc to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.70 means that Akoya Biosciences Inc assets are financed with 70.2% credit (debt) and the remaining percentage (100% - 70.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Akoya Biosciences Inc:

  • The MRQ is 0.702. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.675. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.702TTM0.675+0.027
TTM0.675YOY0.545+0.130
TTM0.6755Y0.524+0.150
5Y0.52410Y0.5240.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7020.353+0.349
TTM0.6750.355+0.320
YOY0.5450.358+0.187
5Y0.5240.362+0.162
10Y0.5240.369+0.155
1.4.2. Debt to Equity Ratio

Measures if Akoya Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Akoya Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 235.4% means that company has $2.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Akoya Biosciences Inc:

  • The MRQ is 2.354. The company is just not able to pay all its debts with equity.
  • The TTM is 2.126. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.354TTM2.126+0.228
TTM2.126YOY1.285+0.841
TTM2.1265Y1.139+0.988
5Y1.13910Y1.1390.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3540.541+1.813
TTM2.1260.545+1.581
YOY1.2850.529+0.756
5Y1.1390.640+0.499
10Y1.1390.665+0.474

2. Market Valuation of Akoya Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Akoya Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Akoya Biosciences Inc to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -5.55 means the investor is paying $-5.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Akoya Biosciences Inc:

  • The EOD is -5.334. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.550. Based on the earnings, the company is expensive. -2
  • The TTM is -4.920. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.334MRQ-5.550+0.216
MRQ-5.550TTM-4.920-0.630
TTM-4.920YOY-7.891+2.970
TTM-4.9205Y-7.223+2.303
5Y-7.22310Y-7.2230.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-5.33417.153-22.487
MRQ-5.55018.041-23.591
TTM-4.92019.435-24.355
YOY-7.89120.661-28.552
5Y-7.22321.526-28.749
10Y-7.22327.509-34.732
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Akoya Biosciences Inc:

  • The EOD is -9.376. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.756. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.356. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.376MRQ-9.756+0.380
MRQ-9.756TTM-6.356-3.400
TTM-6.356YOY-9.373+3.017
TTM-6.3565Y-7.374+1.018
5Y-7.37410Y-7.3740.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-9.37610.417-19.793
MRQ-9.75610.581-20.337
TTM-6.3561.298-7.654
YOY-9.3734.650-14.023
5Y-7.3744.114-11.488
10Y-7.3740.108-7.482
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Akoya Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 4.46 means the investor is paying $4.46 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Akoya Biosciences Inc:

  • The EOD is 4.286. Based on the equity, the company is fair priced.
  • The MRQ is 4.460. Based on the equity, the company is fair priced.
  • The TTM is 5.685. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.286MRQ4.460-0.174
MRQ4.460TTM5.685-1.225
TTM5.685YOY6.934-1.249
TTM5.6855Y4.256+1.429
5Y4.25610Y4.2560.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD4.2862.531+1.755
MRQ4.4602.733+1.727
TTM5.6852.706+2.979
YOY6.9343.244+3.690
5Y4.2563.824+0.432
10Y4.2564.219+0.037
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Akoya Biosciences Inc.

3.1. Institutions holding Akoya Biosciences Inc

Institutions are holding 72.343% of the shares of Akoya Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Blue Water Life Science Advisors, LLC9.559920.0807469778500
2023-12-31Polar Capital Holdings PLC3.21480.0472157975600
2023-12-31Vanguard Group Inc2.86560.00021408157577624.2774
2023-12-31BlackRock Inc2.79250.00021372232-72770-5.036
2023-12-31Parkman Healthcare Partners LLC1.37320.463867478714916428.3785
2023-12-31Uniplan Investment Counsel, Inc.1.37060.254267352311896321.4518
2023-12-31Board of Ttees Leland Stanford Jr Univ1.26260.1963620433-1-0.0002
2023-12-31BP WEALTH MANAGEMENT, LLC1.04870.061251531700
2023-12-31Geode Capital Management, LLC1.01380.0003498175320946.8859
2023-12-31State Street Corporation0.72770.0001357591-432-0.1207
2023-12-31Peddock Capital Advisors, LLC0.59160.4323290720245728546.1593
2023-12-31Northern Trust Corp0.4470.00022196763592819.5529
2023-12-31Charles Schwab Investment Management Inc0.41690.00032048495141033.5052
2023-12-31Millennium Management LLC0.32020.0003157368-385605-71.0173
2023-09-30Schonfeld Strategic Advisors LLC0.26350.004712950072005.8872
2023-12-31Osterweis Capital Management Inc0.25670.039112613100
2023-12-31Kent Lake Capital LLC0.23780.2202116835-629686-84.3494
2023-12-31CIBC Global Asset Management Inc0.23530.002111564473737175.9539
2023-12-31Squarepoint Ops LLC0.19730.000996932-30287-23.807
2023-12-31Morgan Stanley - Brokerage Accounts0.176608679953295159.0706
Total 28.372321.804313942210-293500-2.1%

3.2. Funds holding Akoya Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Polar Capital Biotech S Inc2.54370.3902125000000
2024-02-29Vanguard Total Stock Mkt Idx Inv1.79280.000388101500
2024-02-29iShares Russell 2000 ETF1.04620.0047514103-84-0.0163
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.56230.001627632428001.0237
2023-12-31Fidelity Small Cap Index0.4650.004422851622721.0042
2024-02-29iShares Russell 2000 Growth ETF0.43870.0109215601-251-0.1163
2024-01-31Fidelity Extended Market Index0.2510.001812336500
2024-02-29Schwab US Small-Cap ETF™0.23680.00411638000
2023-11-30Renaissance Global Health Care0.23530.09921156444384161.0573
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.17690.00128694700
2024-02-29Vanguard Russell 2000 ETF0.17480.00528589767408.5147
2024-02-29Vanguard Health Care ETF0.17050.0023837804320.5183
2023-12-31NT R2000 Growth Index Fund - NL0.13390.00876579600
2024-02-29State St Russell Sm Cap® Indx SL Cl I0.13120.00396447600
2023-12-31NT R2000 Index Fund - NL0.12840.0043631051080.1714
2023-09-30BlackRock Extended Mkt Composite0.11090.0018545084400.8138
2023-12-31NT R2000 Growth Index Fund - L0.10760.009352858542111.4278
2023-12-31Northern Trust Russell 2000 Growth Index0.10760.009352858542111.4278
2024-02-29iShares Micro-Cap ETF0.10580.03275197400
2024-01-31Schwab Small Cap Index0.10560.00465189300
Total 9.0250.60044435040+67140+1.5%

3.3. Insider Transactions

Insiders are holding 12.904% of the shares of Akoya Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-13Brian MckelligonSELL75004.94
2023-12-19Brian MckelligonSELL75004.48
2023-09-07Frederic PlaBUY200004.6
2023-06-12John Frederick EkBUY200005
2023-06-12Matthew WinklerBUY2033885
2023-06-06Brian MckelligonSELL50005.71

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Akoya Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.167-0.024-85%-0.319+91%0.068-344%0.068-344%
Book Value Per Share--1.0941.169-6%1.684-35%1.178-7%1.178-7%
Current Ratio--3.4463.218+7%3.522-2%3.248+6%3.248+6%
Debt To Asset Ratio--0.7020.675+4%0.545+29%0.524+34%0.524+34%
Debt To Equity Ratio--2.3542.126+11%1.285+83%1.139+107%1.139+107%
Dividend Per Share---0.000-100%-0%0.007-100%0.007-100%
Eps---0.220-0.322+47%-0.359+63%-0.254+16%-0.254+16%
Free Cash Flow Per Share---0.125-0.277+122%-0.310+148%-0.212+70%-0.212+70%
Free Cash Flow To Equity Per Share--0.1000.012+755%-0.163+264%0.078+28%0.078+28%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---13.168--------
Intrinsic Value_10Y_min---11.316--------
Intrinsic Value_1Y_max---1.101--------
Intrinsic Value_1Y_min---1.081--------
Intrinsic Value_3Y_max---3.474--------
Intrinsic Value_3Y_min---3.313--------
Intrinsic Value_5Y_max---6.048--------
Intrinsic Value_5Y_min---5.599--------
Market Cap230469883.000-4%239806616.000308357892.500-22%554798503.000-57%365084688.063-34%365084688.063-34%
Net Profit Margin---0.408-0.671+64%-0.946+132%-0.695+70%-0.695+70%
Operating Margin---0.333-0.627+88%-0.889+167%-0.614+84%-0.614+84%
Operating Ratio--1.3331.571-15%1.889-29%1.599-17%1.599-17%
Pb Ratio4.286-4%4.4605.685-22%6.934-36%4.256+5%4.256+5%
Pe Ratio-5.334+4%-5.550-4.920-11%-7.891+42%-7.223+30%-7.223+30%
Price Per Share4.690-4%4.8806.275-22%11.290-57%7.429-34%7.429-34%
Price To Free Cash Flow Ratio-9.376+4%-9.756-6.356-35%-9.373-4%-7.374-24%-7.374-24%
Price To Total Gains Ratio-28.096+4%-29.234-16.133-45%-35.458+21%-29.964+2%-29.964+2%
Quick Ratio--2.8332.635+7%3.466-18%2.906-3%2.906-3%
Return On Assets---0.060-0.091+52%-0.098+63%-0.070+17%-0.070+17%
Return On Equity---0.201-0.286+42%-0.227+13%-0.164-18%-0.164-18%
Total Gains Per Share---0.167-0.024-85%-0.319+91%0.075-321%0.075-321%
Usd Book Value--53770000.00057442000.000-6%82767750.000-35%57873375.000-7%57873375.000-7%
Usd Book Value Change Per Share---0.167-0.024-85%-0.319+91%0.068-344%0.068-344%
Usd Book Value Per Share--1.0941.169-6%1.684-35%1.178-7%1.178-7%
Usd Dividend Per Share---0.000-100%-0%0.007-100%0.007-100%
Usd Eps---0.220-0.322+47%-0.359+63%-0.254+16%-0.254+16%
Usd Free Cash Flow---6145000.000-13629750.000+122%-15214000.000+148%-10417187.500+70%-10417187.500+70%
Usd Free Cash Flow Per Share---0.125-0.277+122%-0.310+148%-0.212+70%-0.212+70%
Usd Free Cash Flow To Equity Per Share--0.1000.012+755%-0.163+264%0.078+28%0.078+28%
Usd Market Cap230469883.000-4%239806616.000308357892.500-22%554798503.000-57%365084688.063-34%365084688.063-34%
Usd Price Per Share4.690-4%4.8806.275-22%11.290-57%7.429-34%7.429-34%
Usd Profit---10802000.000-15830750.000+47%-17660250.000+63%-12100312.500+12%-12100312.500+12%
Usd Revenue--26487000.00024158250.000+10%18714750.000+42%16803250.000+58%16803250.000+58%
Usd Total Gains Per Share---0.167-0.024-85%-0.319+91%0.075-321%0.075-321%
 EOD+3 -5MRQTTM+20 -15YOY+22 -115Y+17 -1810Y+17 -18

4.2. Fundamental Score

Let's check the fundamental score of Akoya Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.334
Price to Book Ratio (EOD)Between0-14.286
Net Profit Margin (MRQ)Greater than0-0.408
Operating Margin (MRQ)Greater than0-0.333
Quick Ratio (MRQ)Greater than12.833
Current Ratio (MRQ)Greater than13.446
Debt to Asset Ratio (MRQ)Less than10.702
Debt to Equity Ratio (MRQ)Less than12.354
Return on Equity (MRQ)Greater than0.15-0.201
Return on Assets (MRQ)Greater than0.05-0.060
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Akoya Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4.730
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets180,369
Total Liabilities126,599
Total Stockholder Equity53,770
 As reported
Total Liabilities 126,599
Total Stockholder Equity+ 53,770
Total Assets = 180,369

Assets

Total Assets180,369
Total Current Assets121,790
Long-term Assets58,579
Total Current Assets
Cash And Cash Equivalents 83,125
Net Receivables 16,994
Inventory 17,877
Other Current Assets 3,794
Total Current Assets  (as reported)121,790
Total Current Assets  (calculated)121,790
+/-0
Long-term Assets
Property Plant Equipment 20,656
Goodwill 18,262
Intangible Assets 17,412
Long-term Assets Other 1,550
Long-term Assets  (as reported)58,579
Long-term Assets  (calculated)57,880
+/- 699

Liabilities & Shareholders' Equity

Total Current Liabilities35,345
Long-term Liabilities91,254
Total Stockholder Equity53,770
Total Current Liabilities
Short-term Debt 3,448
Accounts payable 11,776
Other Current Liabilities 13,433
Total Current Liabilities  (as reported)35,345
Total Current Liabilities  (calculated)28,657
+/- 6,688
Long-term Liabilities
Long term Debt 75,254
Capital Lease Obligations 10,452
Long-term Liabilities Other 5,765
Long-term Liabilities  (as reported)91,254
Long-term Liabilities  (calculated)91,471
+/- 217
Total Stockholder Equity
Common Stock2
Retained Earnings -230,071
Other Stockholders Equity 283,839
Total Stockholder Equity (as reported)53,770
Total Stockholder Equity (calculated)53,770
+/-0
Other
Capital Stock2
Cash and Short Term Investments 83,125
Common Stock Shares Outstanding 49,090
Current Deferred Revenue6,688
Liabilities and Stockholders Equity 180,369
Net Debt 2,581
Net Invested Capital 129,024
Net Working Capital 86,445
Property Plant and Equipment Gross 30,319
Short Long Term Debt Total 85,706



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
77,660
74,481
206,342
195,411
190,907
187,128
184,263
176,457
176,031
154,297
188,879
177,244
180,369
180,369177,244188,879154,297176,031176,457184,263187,128190,907195,411206,34274,48177,660000
   > Total Current Assets 
0
0
0
28,696
24,034
157,409
145,660
140,814
126,466
119,894
111,744
112,197
91,674
126,170
116,948
121,790
121,790116,948126,17091,674112,197111,744119,894126,466140,814145,660157,40924,03428,696000
       Cash And Cash Equivalents 
0
0
0
17,006
11,691
135,464
120,150
113,079
93,938
46,881
51,836
74,229
60,247
93,328
78,595
83,125
83,12578,59593,32860,24774,22951,83646,88193,938113,079120,150135,46411,69117,006000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
40,725
29,868
6,989
0
0
0
0
00006,98929,86840,725000000000
       Net Receivables 
0
0
0
6,470
6,590
8,158
9,605
9,444
11,314
10,472
8,680
9,729
12,943
12,866
16,096
16,994
16,99416,09612,86612,9439,7298,68010,47211,3149,4449,6058,1586,5906,470000
       Other Current Assets 
0
0
0
957
1,035
7,225
9,812
9,277
9,841
8,598
8,297
6,764
3,977
3,845
3,505
3,794
3,7943,5053,8453,9776,7648,2978,5989,8419,2779,8127,2251,035957000
   > Long-term Assets 
0
0
0
48,964
50,447
48,933
49,751
50,093
60,662
64,369
64,713
63,834
62,623
62,709
60,296
58,579
58,57960,29662,70962,62363,83464,71364,36960,66250,09349,75148,93350,44748,964000
       Property Plant Equipment 
0
0
0
5,528
6,053
6,020
6,492
7,487
18,572
22,623
23,303
22,449
21,902
22,758
21,622
20,656
20,65621,62222,75821,90222,44923,30322,62318,5727,4876,4926,0206,0535,528000
       Goodwill 
0
0
0
18,262
18,262
18,262
18,262
18,262
18,262
18,262
18,262
18,262
18,262
18,262
18,262
18,262
18,26218,26218,26218,26218,26218,26218,26218,26218,26218,26218,26218,26218,262000
       Intangible Assets 
0
0
0
22,714
22,160
21,644
21,374
21,150
20,960
20,799
20,442
20,048
19,496
19,125
18,123
17,412
17,41218,12319,12519,49620,04820,44220,79920,96021,15021,37421,64422,16022,714000
       Other Assets 
0
0
0
0
3,972
3,007
3,623
3,194
2,868
2,685
2,706
3,075
2,963
2,564
0
0
002,5642,9633,0752,7062,6852,8683,1943,6233,0073,9720000
> Total Liabilities 
0
0
0
59,089
134,481
58,521
58,019
69,556
80,576
93,413
101,369
117,450
112,173
116,978
115,271
126,599
126,599115,271116,978112,173117,450101,36993,41380,57669,55658,01958,521134,48159,089000
   > Total Current Liabilities 
0
0
0
17,162
20,558
18,161
17,300
27,682
31,736
33,783
31,682
37,055
33,223
37,390
35,523
35,345
35,34535,52337,39033,22337,05531,68233,78331,73627,68217,30018,16120,55817,162000
       Short-term Debt 
0
0
0
1,229
1,515
288
279
272
3,188
3,593
3,597
3,629
3,583
3,716
3,589
3,448
3,4483,5893,7163,5833,6293,5973,5933,1882722792881,5151,229000
       Short Long Term Debt 
0
0
0
1,032
1,238
0
0
0
0
0
0
0
0
0
0
0
000000000001,2381,032000
       Accounts payable 
0
0
0
5,074
5,776
4,898
4,071
23,198
11,518
24,875
22,209
27,147
22,983
26,460
25,084
11,776
11,77625,08426,46022,98327,14722,20924,87511,51823,1984,0714,8985,7765,074000
       Other Current Liabilities 
0
0
0
7,015
9,151
8,688
8,596
-272
12,138
11,503
14,037
16,519
10,240
10,930
-74,788
13,433
13,433-74,78810,93010,24016,51914,03711,50312,138-2728,5968,6889,1517,015000
   > Long-term Liabilities 
0
0
0
41,927
113,923
40,360
40,719
41,874
48,840
59,630
69,687
80,395
78,950
79,588
79,748
91,254
91,25479,74879,58878,95080,39569,68759,63048,84041,87440,71940,360113,92341,927000
       Long term Debt Total 
0
0
0
0
33,388
32,256
32,363
32,471
32,576
42,565
52,714
63,277
63,455
63,636
0
0
0063,63663,45563,27752,71442,56532,57632,47132,36332,25633,3880000
       Warrants
0
0
0
0
140,594
0
0
0
0
0
0
0
0
0
0
0
00000000000140,5940000
       Other Liabilities 
0
0
0
0
9,839
7,777
8,356
9,403
8,310
7,278
7,558
8,240
7,258
7,633
0
0
007,6337,2588,2407,5587,2788,3109,4038,3567,7779,8390000
       Deferred Long Term Liability 
0
0
0
0
1,439
154
134
26
36
125
125
87
87
87
0
0
0087878712512536261341541,4390000
> Total Stockholder Equity
0
0
0
18,571
-60,000
147,821
137,392
121,351
106,552
90,850
75,088
58,581
42,124
71,901
61,973
53,770
53,77061,97371,90142,12458,58175,08890,850106,552121,351137,392147,821-60,00018,571000
   Common Stock
0
0
0
2
1
2
2
2
2
2
2
2
2
2
2
2
2222222222212000
   Retained Earnings Total Equity00-206,353-185,550-166,748-147,873-130,001-112,506-96,107-78,434-66,817-61,2540000
   Accumulated Other Comprehensive Income 0000-6-66-9200-195,411-206,342-71,5500000
   Capital Surplus 
0
0
0
0
0
214,636
215,824
217,456
219,056
220,941
223,025
225,333
227,672
278,252
0
0
00278,252227,672225,333223,025220,941219,056217,456215,824214,63600000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
70,849
71,550
214,636
215,824
217,456
219,056
220,941
223,025
225,333
227,672
278,252
281,240
283,839
283,839281,240278,252227,672225,333223,025220,941219,056217,456215,824214,63671,55070,849000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue96,633
Cost of Revenue-48,395
Gross Profit48,23848,238
 
Operating Income (+$)
Gross Profit48,238
Operating Expense-104,270
Operating Income-56,032-56,032
 
Operating Expense (+$)
Research Development21,889
Selling General Administrative84,431
Selling And Marketing Expenses0
Operating Expense104,270106,320
 
Net Interest Income (+$)
Interest Income3,141
Interest Expense-8,761
Other Finance Cost-446
Net Interest Income-5,174
 
Pretax Income (+$)
Operating Income-56,032
Net Interest Income-5,174
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-63,283-48,781
EBIT - interestExpense = -64,793
-63,283
-54,562
Interest Expense8,761
Earnings Before Interest and Taxes (EBIT)-56,032-54,522
Earnings Before Interest and Taxes (EBITDA)-47,142
 
After tax Income (+$)
Income Before Tax-63,283
Tax Provision-36
Net Income From Continuing Ops-71,396-63,319
Net Income-63,323
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses152,665
Total Other Income/Expenses Net-7,2515,174
 

Technical Analysis of Akoya Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Akoya Biosciences Inc. The general trend of Akoya Biosciences Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Akoya Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Akoya Biosciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 5.2 < 6.215 < 6.31.

The bearish price targets are: 4.62 > 4.4 > 4.25.

Tweet this
Akoya Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Akoya Biosciences Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Akoya Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Akoya Biosciences Inc.

Akoya Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartAkoya Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Akoya Biosciences Inc. The current adx is .

Akoya Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Akoya Biosciences Inc.

Akoya Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Akoya Biosciences Inc.

Akoya Biosciences Inc Daily Relative Strength Index (RSI) ChartAkoya Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Akoya Biosciences Inc.

Akoya Biosciences Inc Daily Stochastic Oscillator ChartAkoya Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Akoya Biosciences Inc.

Akoya Biosciences Inc Daily Commodity Channel Index (CCI) ChartAkoya Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Akoya Biosciences Inc.

Akoya Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartAkoya Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Akoya Biosciences Inc.

Akoya Biosciences Inc Daily Williams %R ChartAkoya Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Akoya Biosciences Inc.

Akoya Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Akoya Biosciences Inc.

Akoya Biosciences Inc Daily Average True Range (ATR) ChartAkoya Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Akoya Biosciences Inc.

Akoya Biosciences Inc Daily On-Balance Volume (OBV) ChartAkoya Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Akoya Biosciences Inc.

Akoya Biosciences Inc Daily Money Flow Index (MFI) ChartAkoya Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Akoya Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Akoya Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Akoya Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4.730
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Akoya Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Akoya Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Akoya Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Akoya Biosciences Inc

I send you an email if I find something interesting about Akoya Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Akoya Biosciences Inc.

Receive notifications about Akoya Biosciences Inc in your mailbox!